Growth Metrics

Whitehawk Therapeutics (WHWK) Asset Utilization Ratio (2018 - 2025)

Whitehawk Therapeutics (WHWK) has disclosed Asset Utilization Ratio for 8 consecutive years, with 0.04 as the latest value for Q4 2025.

  • Quarterly Asset Utilization Ratio fell 86.5% to 0.04 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.04 through Dec 2025, down 86.5% year-over-year, with the annual reading at 0.06 for FY2025, 74.79% down from the prior year.
  • Asset Utilization Ratio for Q4 2025 was 0.04 at Whitehawk Therapeutics, down from 0.08 in the prior quarter.
  • The five-year high for Asset Utilization Ratio was 0.39 in Q2 2021, with the low at 0.0 in Q3 2021.
  • Average Asset Utilization Ratio over 5 years is 0.17, with a median of 0.15 recorded in 2022.
  • The sharpest move saw Asset Utilization Ratio tumbled 98.93% in 2021, then soared 4266.5% in 2022.
  • Over 5 years, Asset Utilization Ratio stood at 0.09 in 2021, then dropped by 6.95% to 0.08 in 2022, then skyrocketed by 122.56% to 0.18 in 2023, then soared by 86.06% to 0.33 in 2024, then plummeted by 86.5% to 0.04 in 2025.
  • According to Business Quant data, Asset Utilization Ratio over the past three periods came in at 0.04, 0.08, and 0.1 for Q4 2025, Q3 2025, and Q2 2025 respectively.